Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07325747

Immediate Versus Delayed Surgical Reconstruction of Peri-implantitis Intra-bony Defects.

Immediate Versus Delayed Surgical Reconstruction of Peri-implantitis Intra-bony Defects: A Parallel-arm, Assessor-blind, Randomized, Controlled Clinical Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
University of Michigan · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to test the comparative efficacy of two surgical approaches (immediate versus delayed GBR) for the surgical reconstruction of peri-implantitis intra-bony defects in terms of the clinical, radiographical, histological, volumetric, microbiological, and patient-reported outcomes. The investigators hypothesize that in certain clinical situations, treatment of peri-implantitis intra-bony defects with the use of a compound bone grafting material (mixture of allogenic bone substitutes) and a non-resorbable barrier membrane and following a delayed approach (test group) with initial phase of defect decontamination and initial healing phase would yield superior outcomes to that of the conventional approach (control group) of defect decontamination and regeneration at the same clinical visit while also significantly enhancing patient-reported outcomes: H0: There is no difference between the two mentioned approaches in terms of the treatment outcomes. H1: There is a significant difference, favoring the delayed approach compared to the immediate reconstruction.

Conditions

Interventions

TypeNameDescription
PROCEDUREStaged peri-implant debridement and regenerationPeri-implant debridement will be carried our in visit one and will be followed by a second surgery for regeneration
PROCEDURESimultaneous peri-implant debridement and regenerationThe peri-implant defect will be debrided and regenerated at the same visit.

Timeline

Start date
2026-01-12
Primary completion
2027-02-01
Completion
2028-12-01
First posted
2026-01-08
Last updated
2026-02-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT07325747. Inclusion in this directory is not an endorsement.